Subscribe to RSS
DOI: 10.1055/s-0038-1676648
Indwelling Pleural Catheter Placement for Nonmalignant Pleural Effusions
Publication History
Publication Date:
14 January 2019 (online)
![](https://www.thieme-connect.de/media/srccm/201806/lookinside/thumbnails/10-1055-s-0038-1676648_01416-1.jpg)
Abstract
Pleural effusions account for significant symptoms and morbidity. Recent studies demonstrate a high mortality in patients with “benign” pleural effusions, now better characterized as nonmalignant pleural effusions (NMPEs) based on their prognosis. The most common nonmalignant clinical conditions with recurrent pleural effusions are congestive heart failure and hepatic hydrothorax, although many other diseases exist in isolation or as comorbid conditions. When conventional therapy fails, thoracentesis is often performed for relief of dyspnea. Many times, however, the effusions recur despite maximal medical therapy. Placement of tunneled or indwelling pleural catheters provides an effective therapeutic strategy for recurrent NMPEs when other medical therapy fails.
-
References
- 1 DeBiasi EM, Pisani MA, Murphy TE. , et al. Mortality among patients with pleural effusion undergoing thoracentesis. Eur Respir J 2015; 46 (02) 495-502
- 2 DeBiasi E, Puchalski J. Pleural effusions as markers of mortality and disease severity: a state-of-the-art review. Curr Opin Pulm Med 2016; 22 (04) 386-391
- 3 Walker SP, Morley AJ, Stadon L. , et al. Nonmalignant pleural effusions: a prospective study of 356 consecutive unselected patients. Chest 2017; 151 (05) 1099-1105
- 4 Feller-Kopman D, Light R. Pleural disease. N Engl J Med 2018; 378 (18) 1754
- 5 Chee A, Tremblay A. The use of tunneled pleural catheters in the treatment of pleural effusions. Curr Opin Pulm Med 2011; 17 (04) 237-241
- 6 Bhatnagar R, Reid ED, Corcoran JP. , et al. Indwelling pleural catheters for non-malignant effusions: a multicentre review of practice. Thorax 2014; 69 (10) 959-961
- 7 Daniels CE, Ryu JH. Improving the safety of thoracentesis. Curr Opin Pulm Med 2011; 17 (04) 232-236
- 8 Argento AC, Murphy TE, Pisani MA, Araujo KL, Puchalski J. Patient-centered outcomes following thoracentesis. Pleura (Thousand Oaks) 2015; 2: 2
- 9 Freeman RK, Ascioti AJ, Dake M, Mahidhara RS. A propensity-matched comparison of pleurodesis or tunneled pleural catheter for heart failure patients with recurrent pleural effusion. Ann Thorac Surg 2014; 97 (06) 1872-1876 , discussion 1876–1877
- 10 Glazer M, Berkman N, Lafair JS, Kramer MR. Successful talc slurry pleurodesis in patients with nonmalignant pleural effusion. Chest 2000; 117 (05) 1404-1409
- 11 Sabur NF, Chee A, Stather DR. , et al. The impact of tunneled pleural catheters on the quality of life of patients with malignant pleural effusions. Respiration 2013; 85 (01) 36-42
- 12 Patil M, Dhillon SS, Attwood K, Saoud M, Alraiyes AH, Harris K. Management of benign pleural effusions using indwelling pleural catheters: a systematic review and meta-analysis. Chest 2017; 151 (03) 626-635
- 13 Krishnan M, Cheriyath P, Wert Y, Moritz TA. The untapped potential of tunneled pleural catheters. Ann Thorac Surg 2015; 100 (06) 2055-2057
- 14 Chalhoub M, Harris K, Castellano M, Maroun R, Bourjeily G. The use of the PleurX catheter in the management of non-malignant pleural effusions. Chron Respir Dis 2011; 8 (03) 185-191
- 15 Porcel JM, Esquerda A, Vives M, Bielsa S. Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses. Arch Bronconeumol 2014; 50 (05) 161-165
- 16 Broaddus VC, Wiener-Kronish JP, Staub NC. Clearance of lung edema into the pleural space of volume-loaded anesthetized sheep. J Appl Physiol (1985) 1990; 68 (06) 2623-2630
- 17 Kataoka H. Pericardial and pleural effusions in decompensated chronic heart failure. Am Heart J 2000; 139 (05) 918-923
- 18 Edwards JE, Race GA, Scheifley CH. Hydrothorax in congestive heart failure. Am J Med 1957; 22 (01) 83-89
- 19 Chalhoub M, Ali Z, Sasso L, Castellano M. Experience with indwelling pleural catheters in the treatment of recurrent pleural effusions. Ther Adv Respir Dis 2016; 10 (06) 566-572
- 20 Davidoff D, Naparstek Y, Eliakim M. The use of pleurodesis for intractable pleural effusion due to congestive heart failure. Postgrad Med J 1983; 59 (691) 330-331
- 21 Herlihy JP, Loyalka P, Gnananandh J. , et al. PleurX catheter for the management of refractory pleural effusions in congestive heart failure. Tex Heart Inst J 2009; 36 (01) 38-43
- 22 Srour N, Potechin R, Amjadi K. Use of indwelling pleural catheters for cardiogenic pleural effusions. Chest 2013; 144 (05) 1603-1608
- 23 Majid A, Kheir F, Fashjian M. , et al. Tunneled pleural catheter placement with and without talc poudrage for treatment of pleural effusions due to congestive heart failure. Ann Am Thorac Soc 2016; 13 (02) 212-216
- 24 Singh A, Bajwa A, Shujaat A. Evidence-based review of the management of hepatic hydrothorax. Respiration 2013; 86 (02) 155-173
- 25 Garbuzenko DV, Arefyev NO. Hepatic hydrothorax: an update and review of the literature. World J Hepatol 2017; 9 (31) 1197-1204
- 26 Orman ES, Lok AS. Outcomes of patients with chest tube insertion for hepatic hydrothorax. Hepatol Int 2009; 3 (04) 582-586
- 27 Milanez de Campos JR, Filho LO, de Campos Werebe E. , et al. Thoracoscopy and talc poudrage in the management of hepatic hydrothorax. Chest 2000; 118 (01) 13-17
- 28 Murthy SC, Okereke I, Mason DP, Rice TW. A simple solution for complicated pleural effusions. J Thorac Oncol 2006; 1 (07) 697-700
- 29 Chen A, Massoni J, Jung D, Crippin J. Indwelling tunneled pleural catheters for the management of hepatic hydrothorax. A pilot study. Ann Am Thorac Soc 2016; 13 (06) 862-866
- 30 Kniese C, Diab K, Ghabril M, Bosslet G. Indwelling pleural catheters in hepatic hydrothorax: a single-center series of outcomes and complications. Chest 2018; S0012-3692(18)31053-5
- 31 Shojaee S, Rahman N, Haas K. , et al. Indwelling tunneled pleural catheters for refractory hepatic hydrothorax in patients with cirrhosis: a multicenter study. Chest 2018; pii: S0012-3692(18)32281-5
- 32 Haas KP, Chen AC. Indwelling tunneled pleural catheters for the management of hepatic hydrothorax. Curr Opin Pulm Med 2017; 23 (04) 351-356
- 33 Porcel JM. Management of refractory hepatic hydrothorax. Curr Opin Pulm Med 2014; 20 (04) 352-357
- 34 Potechin R, Amjadi K, Srour N. Indwelling pleural catheters for pleural effusions associated with end-stage renal disease: a case series. Ther Adv Respir Dis 2015; 9 (01) 22-27
- 35 Davies HE, Rahman NM, Parker RJ, Davies RJ. Use of indwelling pleural catheters for chronic pleural infection. Chest 2008; 133 (02) 546-549
- 36 Fysh ETH, Bielsa S, Budgeon CA. , et al. Predictors of clinical use of pleurodesis and/or indwelling pleural catheter therapy for malignant pleural effusion. Chest 2015; 147 (06) 1629-1634
- 37 DePew ZS, Iqbal S, Mullon JJ, Nichols FC, Maldonado F. The role for tunneled indwelling pleural catheters in patients with persistent benign chylothorax. Am J Med Sci 2013; 346 (05) 349-352
- 38 Luks V, Aljohaney A, Amjadi K. Tunneled pleural catheters in the management of chylothorax from central venous catheter-related superior vena cava obstruction. Respiration 2013; 86 (01) 67-71
- 39 Jimenez CA, Mhatre AD, Martinez CH, Eapen GA, Onn A, Morice RC. Use of an indwelling pleural catheter for the management of recurrent chylothorax in patients with cancer. Chest 2007; 132 (05) 1584-1590
- 40 Vakil N, Su JW, Mason DP, Reyes KM, Murthy SC, Pettersson GB. Allograft entrapment after lung transplantation: a simple solution using a pleurocutaneous catheter. Thorac Cardiovasc Surg 2010; 58 (05) 299-301
- 41 Skalski JH, Pannu J, Sasieta HC, Edell ES, Maldonado F. Tunneled indwelling pleural catheters for refractory pleural effusions after solid organ transplant. A case-control study. Ann Am Thorac Soc 2016; 13 (08) 1294-1298